Back
Direxion Daily Gold Miners Bull 2X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Sell
37
NUGT
Direxion Daily Gold Miners Bull 2X ETF
Last Price:
42.70
Seasonality Move:
13.71%
Sell
47
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
59.85
Seasonality Move:
16.48%
Sell
37
Direxion Daily Gold Miners Bull 2X ETF (NUGT)
is a Sell
Is Direxion Daily Gold Miners Bull 2X ETF a Buy, Sell or Hold?
- The current Direxion Daily Gold Miners Bull 2X ETF [NUGT] share price is $42.70. The Score for NUGT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- NUGT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $59.65. The Score for BIB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUGT Stock Price Chart
What is Direxion Daily Gold Miners Bull 2X ETF's stock price today?
-
The Direxion Daily Gold Miners Bull 2X ETF share price today is $42.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGT is experiencing selling pressure, which indicates risk of future bearish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $59.65
The current trend is relatively stagnant and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
NUGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.03 | Sell |
Relative Strength Index (14 RSI): | 42.26 | Sell |
Chaikin Money Flow: | -1324525 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.02 - 51.28) | Sell |
Bollinger Bands (100): | (42.74 - 51.94) | Sell |
BIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.54 | Sell |
Relative Strength Index (14 RSI): | 49.36 | Sell |
Chaikin Money Flow: | 5357 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.39 - 64.31) | Sell |
Bollinger Bands (100): | (60.2 - 67) | Sell |
NUGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.21 | Sell |
20-day SMA: | 44.2 | Sell |
50-day SMA: | 49.05 | Sell |
200-day SMA: | 41.73 | Buy |
8-day EMA: | 42.93 | Sell |
20-day EMA: | 44.61 | Sell |
50-day EMA: | 46.79 | Sell |
200-day EMA: | 43.1 | Sell |
BIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.22 | Buy |
20-day SMA: | 59.86 | Sell |
50-day SMA: | 61.92 | Sell |
200-day SMA: | 59.96 | Sell |
8-day EMA: | 57.88 | Buy |
20-day EMA: | 59.17 | Buy |
50-day EMA: | 61.18 | Sell |
200-day EMA: | 60.1 | Sell |
Direxion Daily Gold Miners Bull 2X ETF Earnings Growth & NUGT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Gold Miners Bull 2X ETF Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |